Q01959 (SC6A3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 139.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sodium-dependent dopamine transporter Short name=DA transporter Short name=DAT Alternative name(s): Solute carrier family 6 member 3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 620 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals. |
| Subunit structure | Homooligomer; disulfide-linked. Interacts with PRKCABP and TGFB1I1. Interacts (via N-terminus) with SYNGR3 (via N-terminus) By similarity. Interacts with SLC18A2 By similarity. Ref.13 Ref.14 Ref.15 |
| Subcellular location | |
| Involvement in disease | Parkinsonism-dystonia infantile (PKDYS) [MIM:613135]: A neurodegenerative disorder characterized by infantile onset of parkinsonism and dystonia. Other neurologic features include global developmental delay, bradikinesia and pyramidal tract signs. |
| Miscellaneous | This protein is the target of psychomotor stimulants such as amphetamines or cocaine. |
| Sequence similarities | Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. SLC6A3 subfamily. [View classification] |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 620 | 620 | Sodium-dependent dopamine transporter | PRO_0000214751 | |||||
Regions | |||||||||
| Topological domain | 1 – 68 | 68 | Cytoplasmic Potential | ||||||
| Transmembrane | 69 – 89 | 21 | Helical; Name=1; Potential | ||||||
| Transmembrane | 96 – 116 | 21 | Helical; Name=2; Potential | ||||||
| Transmembrane | 140 – 160 | 21 | Helical; Name=3; Potential | ||||||
| Topological domain | 161 – 237 | 77 | Extracellular Potential | ||||||
| Transmembrane | 238 – 256 | 19 | Helical; Name=4; Potential | ||||||
| Transmembrane | 265 – 282 | 18 | Helical; Name=5; Potential | ||||||
| Transmembrane | 318 – 335 | 18 | Helical; Name=6; Potential | ||||||
| Transmembrane | 347 – 368 | 22 | Helical; Name=7; Potential | ||||||
| Transmembrane | 401 – 420 | 20 | Helical; Name=8; Potential | ||||||
| Transmembrane | 447 – 465 | 19 | Helical; Name=9; Potential | ||||||
| Transmembrane | 481 – 501 | 21 | Helical; Name=10; Potential | ||||||
| Transmembrane | 522 – 541 | 20 | Helical; Name=11; Potential | ||||||
| Transmembrane | 560 – 578 | 19 | Helical; Name=12; Potential | ||||||
| Topological domain | 579 – 620 | 42 | Cytoplasmic Potential | ||||||
| Region | 561 – 590 | 30 | Interaction with TGFB1I1 | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 181 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 188 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 205 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Disulfide bond | 306 | Interchain Ref.14 | |||||||
Natural variations | |||||||||
| Natural variant | 121 | 1 | G → S in a breast cancer sample; somatic mutation. Ref.18 | VAR_036158 | |||||
| Natural variant | 237 | 1 | R → Q. Ref.16 Corresponds to variant rs6345 [ dbSNP | Ensembl ]. | VAR_014180 | |||||
| Natural variant | 368 | 1 | L → Q in PKDYS; loss of function. Ref.19 | VAR_063771 | |||||
| Natural variant | 395 | 1 | P → L in PKDYS; loss of function. Ref.19 | VAR_063772 | |||||
| Natural variant | 471 | 1 | V → I. Ref.20 Corresponds to variant rs75916702 [ dbSNP | Ensembl ]. | VAR_064580 | |||||
| Natural variant | 544 | 1 | R → S in a breast cancer sample; somatic mutation. Ref.18 | VAR_036159 | |||||
Experimental info | |||||||||
| Sequence conflict | 35 | 1 | K → M in AAB23443. Ref.2 | ||||||
| Sequence conflict | 345 | 1 | D → H Ref.11 | ||||||
| Sequence conflict | 354 | 1 | S → C in AAB23443. Ref.2 | ||||||
| Sequence conflict | 367 | 1 | F → S Ref.11 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs." Vandenbergh D.J., Persico A.M., Uhl G.R. Brain Res. Mol. Brain Res. 15:161-166(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter." Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Mol. Pharmacol. 42:383-390(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [3] | "Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding." Pristupa Z.B., Wilson J.M., Hoffman B.J., Kish S.J., Niznik H.B. Mol. Pharmacol. 45:125-135(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [4] | "Structure and organization of the gene encoding human dopamine transporter." Kawarai T., Kawakami H., Yamamura Y., Nakamura S. Gene 195:11-18(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations." Vandenbergh D.J., Thompson M.D., Cook E.H., Bendahhou E., Nguyen T., Krasowski M.D., Zarrabian D., Comings D., Sellers E.M., Tyndale R.F., George S.R., O'Dowd B.F., Uhl G.R. Mol. Psychiatry 5:283-292(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder." Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., Kelsoe J.R. Am. J. Med. Genet. 105:145-151(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [7] | "Sequence variation in the primate dopamine transporter gene and its relationship to social dominance." Miller-Butterworth C.M., Kaplan J.R., Shaffer J., Devlin B., Manuck S.B., Ferrell R.E. Mol. Biol. Evol. 25:18-28(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [8] | NIEHS SNPs program Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [9] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [11] | "Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures." Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R., Nanthakumar E., Uhl G.R. Brain Res. Mol. Brain Res. 30:327-335(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-385. |
| [12] | "Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age." Bannon M.J., Poosch M.S., Xia Y., Goebel D.J., Cassin B., Kapatos G. Proc. Natl. Acad. Sci. U.S.A. 89:7095-7099(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 164-255. |
| [13] | "Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1." Torres G.E., Yao W.-D., Mohn A.R., Quan H., Kim K.-M., Levey A.I., Staudinger J., Caron M.G. Neuron 30:121-134(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PRKCABP. |
| [14] | "Symmetrical homodimer of the human dopamine transporter revealed by cross-linking Cys306 at the extracellular end of TM6." Hastrup H., Karlin A., Javitch J.A. Abstr. - Soc. Neurosci. 27:1866-1866(2001) Cited for: INTERCHAIN DISULFIDE BOND. |
| [15] | "The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter." Carneiro A.M.D., Ingram S.L., Beaulieu J.-M., Sweeney A., Amara S.G., Thomas S.M., Caron M.G., Torres G.E. J. Neurosci. 22:7045-7054(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TGFB1I1. |
| [16] | "Characterization of single-nucleotide polymorphisms in coding regions of human genes." Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 22:231-238(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GLN-237. |
| [17] | Erratum Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 23:373-373(1999) |
| [18] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] SER-121 AND SER-544. |
| [19] | "Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia." Kurian M.A., Zhen J., Cheng S.Y., Li Y., Mordekar S.R., Jardine P., Morgan N.V., Meyer E., Tee L., Pasha S., Wassmer E., Heales S.J., Gissen P., Reith M.E., Maher E.R. J. Clin. Invest. 119:1595-1603(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PKDYS GLN-368 AND LEU-395, CHARACTERIZATION OF VARIANTS PKDYS GLN-368 AND LEU-395. |
| [20] | "A population-specific HTR2B stop codon predisposes to severe impulsivity." Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T., Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A., Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J., Peltonen L., Virkkunen M., Goldman D. Nature 468:1061-1066(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-471. |
| + | Additional computationally mapped references. |
Web resources
| NIEHS-SNPs |
| Wikipedia Dopamine transporter entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M95167 mRNA. Translation: AAC41720.1. S46955 mRNA. Translation: AAA11754.1. S44626 mRNA. Translation: AAB23443.1. L24178 mRNA. Translation: AAA19560.1. D88570 Genomic DNA. Translation: BAA22511.1. AF119117 Genomic DNA. Translation: AAC50179.2. AF321321 AF306564 Genomic DNA. Translation: AAG33844.1.EF174603 mRNA. Translation: ABO77644.1. AY623110 Genomic DNA. Translation: AAT38106.1. CH471102 Genomic DNA. Translation: EAX08159.1. BC132977 mRNA. Translation: AAI32978.1. BC133003 mRNA. Translation: AAI33004.1. M96670 mRNA. Translation: AAA35770.1. |
| IPI | IPI00219765. |
| PIR | A48980. I57937. I84455. |
| RefSeq | NP_001035.1. NM_001044.4. |
| UniGene | Hs.406. |
3D structure databases | |
| ProteinModelPortal | Q01959. |
| ModBase | Search... |
Protein-protein interaction databases | |
| MINT | MINT-576917. |
| STRING | 9606.ENSP00000270349. |
Protein family/group databases | |
| TCDB | 2.A.22.1.3. neurotransmitter:sodium symporter (NSS) family. |
PTM databases | |
| PhosphoSite | Q01959. |
Polymorphism databases | |
| DMDM | 266667. |
Proteomic databases | |
| PaxDb | Q01959. |
| PRIDE | Q01959. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000270349; ENSP00000270349; ENSG00000142319. ENST00000453492; ENSP00000399806; ENSG00000142319. |
| GeneID | 6531. |
| KEGG | hsa:6531. |
| UCSC | uc003jck.3. human. |
Organism-specific databases | |
| CTD | 6531. |
| GeneCards | GC05M001392. |
| HGNC | HGNC:11049. SLC6A3. |
| HPA | CAB016249. HPA013602. |
| MIM | 126455. gene. 613135. phenotype. |
| neXtProt | NX_Q01959. |
| Orphanet | 238455. Infantile dystonia-parkinsonism. |
| PharmGKB | PA311. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0733. |
| HOGENOM | HOG000116406. |
| HOVERGEN | HBG071421. |
| InParanoid | Q01959. |
| KO | K05036. |
| OMA | SPNCSDA. |
| OrthoDB | EOG46HG9B. |
| PhylomeDB | Q01959. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | alphasynuclein_pathway. Alpha-synuclein signaling. |
| Reactome | REACT_13685. Neuronal System. REACT_15518. Transmembrane transport of small molecules. REACT_20679. Amine compound SLC transporters. |
| SABIO-RK | Q01959. |
Gene expression databases | |
| ArrayExpress | Q01959. |
| Bgee | Q01959. |
| CleanEx | HS_SLC6A3. |
| Genevestigator | Q01959. |
| GermOnline | ENSG00000142319. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000175. Na/ntran_symport. IPR002436. Na/ntran_symport_dopamine. [Graphical view] |
| PANTHER | PTHR11616. PTHR11616. 1 hit. |
| Pfam | PF00209. SNF. 1 hit. [Graphical view] |
| PRINTS | PR01202. DOPTRANSPORT. PR00176. NANEUSMPORT. |
| PROSITE | PS00610. NA_NEUROTRAN_SYMP_1. 1 hit. PS00754. NA_NEUROTRAN_SYMP_2. 1 hit. PS50267. NA_NEUROTRAN_SYMP_3. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q01959. |
| ChEMBL | CHEMBL238. |
| DrugBank | DB00182. Amphetamine. DB00245. Benztropine. DB01156. Bupropion. DB01161. Chloroprocaine. DB00907. Cocaine. DB01576. Dextroamphetamine. DB00937. Diethylpropion. DB00476. Duloxetine. DB01463. Fencamfamine. DB00579. Mazindol. DB00422. Methylphenidate. DB00745. Modafinil. DB00830. Phenmetrazine. DB00191. Phentermine. DB00721. Procaine. |
| GenomeRNAi | 6531. |
| NextBio | 25411. |
| PMAP-CutDB | Q01959. |
| SOURCE | Search... |
Entry information
| Entry name | SC6A3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q01959 Secondary accession number(s): A2RUN4, Q14996 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
